GetTopicDetailResponse(id=68bc318438, topicName=Balversa, introduction=Balversa, content=null, image=null, comments=2, allHits=1002, url=https://h5.medsci.cn/topic?id=3184, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=88737, tagList=[TagDto(tagId=88737, tagName=Balversa)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1331923, encodeId=d99d133192362, content=<a href='/topic/show?id=68bc318438' target=_blank style='color:#2F92EE;'>#Balversa#</a>, objectTitle=強生的膀胱癌靶向治療藥物Balversa在美國獲批, objectType=article, longId=164357, objectId=a0b416435e0c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0b416435e0c, replyNumber=0, likeNumber=74, createdTime=2019-04-17, rootId=0, userName=12498761m56暫無昵稱, userId=b78f2500065, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0b416435e0c, moduleTitle=強生的膀胱癌靶向治療藥物Balversa在美國獲批, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a0b416435e0c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1331922, encodeId=635c1331922fd, content=<a href='/topic/show?id=68bc318438' target=_blank style='color:#2F92EE;'>#Balversa#</a>, objectTitle=轉移性膀胱癌的**靶向治療藥物：Balversa（erdafitinib）在美國加速獲批, objectType=article, longId=164214, objectId=c97916421410, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c97916421410, replyNumber=0, likeNumber=68, createdTime=2019-04-15, rootId=0, userName=12498761m56暫無昵稱, userId=b78f2500065, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c97916421410, moduleTitle=轉移性膀胱癌的**靶向治療藥物：Balversa（erdafitinib）在美國加速獲批, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c97916421410)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
